BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37845658)

  • 21. Use of the 33-Item Hypomania Checklist (HCL-33) to Distinguish Bipolar Disorder From Major Depressive Disorder in Older Adults.
    Zhang X; Li W; Zhao N; Cheung T; Ungvari GS; Wang G; Xiang YT; Angst J
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):410-417. PubMed ID: 34044653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating T-cell subsets discrepancy between bipolar disorder and major depressive disorder during mood episodes: A naturalistic, retrospective study of 1015 cases.
    Li S; Lv D; Qian C; Jiang J; Zhang P; Xi C; Wu L; Gao X; Fu Y; Zhang D; Chen Y; Huang H; Zhu Y; Wang X; Lai J; Hu S
    CNS Neurosci Ther; 2024 Feb; 30(2):e14361. PubMed ID: 37491837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminating bipolar depression from major depressive disorder with polygenic risk scores.
    Liebers DT; Pirooznia M; Ganna A; ; Goes FS
    Psychol Med; 2021 Jul; 51(9):1451-1458. PubMed ID: 32063240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AI algorithm combined with RNA editing-based blood biomarkers to discriminate bipolar from major depressive disorders in an external validation multicentric cohort.
    Salvetat N; Checa-Robles FJ; Delacrétaz A; Cayzac C; Dubuc B; Vetter D; Dainat J; Lang JP; Gamma F; Weissmann D
    J Affect Disord; 2024 Jul; 356():385-393. PubMed ID: 38615844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-derived growth factor BB: A potential diagnostic blood biomarker for differentiating bipolar disorder from major depressive disorder.
    Idemoto K; Ishima T; Niitsu T; Hata T; Yoshida S; Hattori K; Horai T; Otsuka I; Yamamori H; Toda S; Kameno Y; Ota K; Oda Y; Kimura A; Hashimoto T; Mori N; Kikuchi M; Minabe Y; Hashimoto R; Hishimoto A; Nakagome K; Iyo M; Hashimoto K
    J Psychiatr Res; 2021 Feb; 134():48-56. PubMed ID: 33360224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the 33-item Hypomania Checklist (HCL-33) in screening adolescents with bipolar disorder.
    Zhang Y; Li W; Zhang WY; He F; Pan HP; Cheung T; Ungvari GS; Li S; Xiang YT; Angst J
    J Affect Disord; 2021 Feb; 281():786-791. PubMed ID: 33229023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis.
    Fernandes BS; Gama CS; Kauer-Sant'Anna M; Lobato MI; Belmonte-de-Abreu P; Kapczinski F
    J Psychiatr Res; 2009 Oct; 43(15):1200-4. PubMed ID: 19501841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
    McIntyre RS; Soczynska JK; Cha DS; Woldeyohannes HO; Dale RS; Alsuwaidan MT; Gallaugher LA; Mansur RB; Muzina DJ; Carvalho A; Kennedy SH
    J Affect Disord; 2015 Feb; 172():259-64. PubMed ID: 25451425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amygdala and whole-brain activity to emotional faces distinguishes major depressive disorder and bipolar disorder.
    Fournier JC; Keener MT; Almeida J; Kronhaus DM; Phillips ML
    Bipolar Disord; 2013 Nov; 15(7):741-52. PubMed ID: 23911154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sociodemographic and clinical features of bipolar disorder patients misdiagnosed with major depressive disorder in China.
    Xiang YT; Zhang L; Wang G; Hu C; Ungvari GS; Dickerson FB; Kilbourne AM; Si TM; Fang YR; Lu Z; Yang HC; Lai KY; Lee EH; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    Bipolar Disord; 2013 Mar; 15(2):199-205. PubMed ID: 23437963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypomanic symptoms assessed by the HCL-32 in patients with major depressive disorder: a multicenter trial across China.
    Yang HC; Xiang YT; Liu TB; Han R; Wang G; Hu C; Li LJ; Wang XP; Peng HJ; Si TM; Fang YR; Yuan CM; Lu Z; Hu J; Chen ZY; Huang Y; Sun J; Li HC; Zhang JB; Angst J
    J Affect Disord; 2012 Dec; 143(1-3):203-7. PubMed ID: 22840613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of inflammatory, nutrient, and neurohormonal indicators in patients with schizophrenia, bipolar disorder and major depressive disorder.
    Lyu N; Xing G; Yang J; Zhu X; Zhao X; Zhang L; Wang G
    J Psychiatr Res; 2021 May; 137():401-408. PubMed ID: 33765452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on exosomes for identifying bipolar disorder in early stage: A cross-sectional and validation study protocol.
    Wu Y; Li Y; An X; Li J; Yang C; Wang Y
    Brain Behav; 2024 Apr; 14(4):e3494. PubMed ID: 38641892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.
    Li Z; Zhang C; Fan J; Yuan C; Huang J; Chen J; Yi Z; Wang Z; Hong W; Wang Y; Lu W; Guan Y; Wu Z; Su Y; Cao L; Hu Y; Hao Y; Liu M; Yu S; Cui D; Xu L; Song Y; Fang Y
    Br J Psychiatry; 2014 Jul; 205(1):29-35. PubMed ID: 24764546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the screening property of the shortened versions of the Hypomania Checklist-32 (HCL-32): Cross-validation in Korean patients with bipolar disorder and major depressive disorder.
    Kim BN; Lee EH; Kim HJ; Kim JH
    J Affect Disord; 2018 Feb; 227():384-390. PubMed ID: 29149757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptoms and Characteristics of Youth Hospitalized for Depression: Subthreshold Manic Symptoms Can Help Differentiate Bipolar from Unipolar Depression.
    Van Meter A; Correll CU; Ahmad W; Dulin M; Saito E
    J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):545-552. PubMed ID: 34637626
    [No Abstract]   [Full Text] [Related]  

  • 40. Validating a two-dimensional bipolar spectrum model integrating DSM-5's mixed features specifier for Major Depressive Disorder.
    Ferentinos P; Fountoulakis KN; Lewis CM; Porichi E; Dikeos D; Papageorgiou C; Douzenis A
    Compr Psychiatry; 2017 Aug; 77():89-99. PubMed ID: 28647613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.